2care4care: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
2care4care
Largest movements
- Receivables within one year +€5,139
up €5,139 (+105%), from €4,883 to €10,022
of which Other amounts receivable: +€4,759
- Cash +€1,989
up €1,989 (+7.8%), from €25,588 to €27,577
mainly Provisions (+€25,000) and Trade debts (+€398)
- Provisions +€25,000
up €25,000 (+83.3%), from €30,000 to €55,000
- Other debts -€17,500
down €17,500 (-29.5%), from €59,350 to €41,850
- Profit (loss) carried forward -€829
down €829 (-1.2%), from -€67,165 to -€67,994
- Trade debts +€398
up €398 (+175%), from €227 to €625
- Gross operating margin +€649
up €649 (+2.7%), from €24,142 to €24,791
- Financial income -€270
no longer reported in 2025 (was €270)
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €30,471 | €37,599 | +€7,128 | +23.4% |
| Current assets | 29/58 | €30,471 | €37,599 | +€7,128 | +23.4% |
| Amounts receivable within one year | 40/41 | €4,883 | €10,022 | +€5,139 | +105% |
| Trade receivables | 40 | €3,239 | €3,619 | +€380 | +11.7% |
| Other amounts receivable | 41 | €1,644 | €6,403 | +€4,759 | +290% |
| Cash at bank and in hand | 54/58 | €25,588 | €27,577 | +€1,989 | +7.8% |
| Total equity and liabilities | 10/49 | €30,471 | €37,599 | +€7,128 | +23.4% |
| Equity | 10/15 | -€59,105 | -€59,934 | -€829 | -1.4% |
| Contributions | 10/11 | €6,200 | €6,200 | = | 0.0% |
| Reserves | 13 | €1,860 | €1,860 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€67,165 | -€67,994 | -€829 | -1.2% |
| Provisions and deferred taxes | 16 | €30,000 | €55,000 | +€25,000 | +83.3% |
| Provisions for liabilities and charges | 160/5 | €30,000 | €55,000 | +€25,000 | +83.3% |
| Pensions and similar obligations | 160 | €30,000 | €55,000 | +€25,000 | +83.3% |
| Amounts payable | 17/49 | €59,577 | €42,533 | -€17,043 | -28.6% |
| Amounts payable within one year | 42/48 | €59,577 | €42,533 | -€17,043 | -28.6% |
| Trade debts | 44 | €227 | €625 | +€398 | +175% |
| Suppliers | 440/4 | €227 | €625 | +€398 | +175% |
| Advances received on contracts in progress | 46 | - | €39 | +€39 | |
| Taxes, remuneration and social security | 45 | - | €20 | +€20 | |
| Taxes | 450/3 | - | €20 | +€20 | |
| Other amounts payable | 47/48 | €59,350 | €41,850 | -€17,500 | -29.5% |
| Other operating charges | 640/8 | €611 | €545 | -€66 | -10.9% |
| Non-recurring operating charges | 66A | €30,000 | €25,000 | -€5,000 | -16.7% |
| Gross operating margin | 9900 | €24,142 | €24,791 | +€649 | +2.7% |
| Operating profit (loss) | 9901 | -€6,469 | -€754 | +€5,716 | +88.3% |
| Financial income | 75/76B | €270 | - | -€270 | |
| Recurring financial income | 75 | €270 | - | -€270 | |
| Financial charges | 65/66B | €45 | €75 | +€30 | +66.7% |
| Recurring financial charges | 65 | €45 | €75 | +€30 | +66.7% |
| Profit (loss) for the period before taxes | 9903 | -€6,244 | -€829 | +€5,416 | +86.7% |
| Profit (loss) for the period | 9904 | -€6,244 | -€829 | +€5,416 | +86.7% |
| Profit (loss) for the period to be appropriated | 9905 | -€6,244 | -€829 | +€5,416 | +86.7% |
Source: filed annual accounts (NBB), financial years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.